STATE OF NEW YORK ________________________________________________________________________ 3350 2023-2024 Regular Sessions IN SENATE January 30, 2023 ___________ Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to requiring practi- tioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 9 of section 3343-a of the public health law is 2 renumbered subdivision 10 and a new subdivision 9 is added to read as 3 follows: 4 9. Administration of overdose reversal agents. (a) Any practitioner 5 who administers naloxone or another overdose reversal agent to a patient 6 in the case of a suspected or confirmed overdose shall report the admin- 7 istration of the agent to the prescription monitoring program registry 8 within seventy-two hours of administration. Such report shall contain 9 the following information if available: (i) the name of the patient; 10 (ii) the address of the patient; (iii) the date of birth of the patient; 11 (iv) the time and place of the administration of the agent; and (v) the 12 identity of the person who administered the naloxone to the patient. 13 (b) Any report made pursuant to the terms of this subdivision shall be 14 considered to be made by the reporter in the course of his or her duties 15 and shall be directly related to patient care. 16 § 2. This act shall take effect January 1, 2025. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD08239-01-3